Stories

Personnel changes at the U.S. Department of Health and Human Services have affected vapor regulation. Despite reductions in cigarette smoking attributed to e-cigarettes, public health groups criticize them. E-cigarettes were created for smoking cessation, but Big Tobacco's involvement grew due to FDA regulations. FDA approval is challenging, hindering innovation. The U.S. lags in recognizing e-cigarettes' harm reduction benefits compared to other countries. Big Tobacco influence and regulatory barriers impact the availability of safer vaping options for adult smokers. President Trump aimed to protect flavored vaping products, with millions of adults in support. Federal regulations need to align with science and consumer needs to support harm reduction efforts.

What’s it like to fight for vaping in a world hostile to tobacco harm reduction? Advocate Skip Murray opens up about the soul-crushing closure of her vape shop, the rise of media scare tactics, and why she believes kindness—not outrage—is the key to saving lives.

The Australian pharmacy-only vaping model is failing, with 75% of pharmacies not stocking vaping products. The government's restrictive approach has led to limited product availability, half of which are supplied by Big Tobacco. Critics argue that pharmacies are uninterested due to paperwork and reputation concerns. Advocates call for reform to allow licensed vape retailers to meet demand. As legal access declines, a dangerous black market is emerging. Vapers report confusion and disinterest from pharmacies, highlighting the model's flaws. The ALIVE Advocacy Movement urges immediate change to prevent further harm and reliance on illegal sources.

Poland is considering a ban on disposable vapes, following France and Belgium. The proposed legislation aims to prohibit all single-use vapes, raising concerns about a potential shift in European regulations impacting the vaping industry. The ban is part of Poland's effort to reduce youth access to affordable vaping products. Proponents argue it will protect public health, while critics fear it may lead to tax revenue losses and illegal sales. Similar bans in France and Belgium suggest a growing trend in Europe towards stricter regulations on vaping products. The long-term effects of these bans remain uncertain, with debates ongoing about their efficacy in reducing harm.

Consumer behavior in purchasing drugs, including vapes, is not significantly affected by regulation. Buyers often choose unregulated vapes due to better value and convenience. For example, a 600-puff vape costs £6, while a 3,500-puff vape is priced at £12, providing more liquid for a slightly higher cost.

Senator Ashley Moody challenged Dr. Martin Makary during a U.S. Senate committee hearing on e-cigarettes, perpetuating misconceptions about Chinese-made vapes flooding the market. Despite focusing on youth vaping, Sen. Moody's claims disregard the declining rates. She opposes flavored e-cigarettes popular among adults, ignoring their role in smoking cessation. While condemning vapes, she overlooks stress as a reason for teen vaping. Scientific data supports vaping as a smoking cessation strategy, contrasting Moody's anti-vape stance favored by Big Tobacco. It is crucial to prioritize harm reduction over misinformation and corporate agendas in regulating vaping products.

Tobacco harm reduction aims to lessen the health impact of smoking. While quitting smoking is the safest option, not all smokers are ready. Smokeless alternatives like nicotine pouches offer a lower-risk choice for those unwilling to quit. Countries like Sweden lead in promoting these alternatives, such as nicotine pouches like Velo. These pouches do not contain tobacco, making them a safer option. Velo provides a modern alternative for adult smokers seeking a less harmful way to consume nicotine. It aligns with a global effort to reduce tobacco harm, although not without risks and addiction potential.

Researchers in New Zealand are investigating the long-term health effects of vaping, especially among youth who are increasingly using e-cigarettes. Concerns about the impact on respiratory health and potential diseases are growing, as vaping is relatively new compared to smoking. Studies have found various chemicals and heavy metals in vape aerosols, raising safety questions. Efforts to address vaping addiction include proposing plain, tobacco-flavored vapes to reduce the appeal to young users. New Zealand's upcoming regulations will ban disposable vapes and limit displays in stores, aligning with research efforts to understand the health implications of vaping.

Toxicological and epidemiological studies suggest that new-generation nicotine delivery products will reduce the harmful exposures associated with combustible cigarettes and toxic forms of smokeless tobacco products. However, enhanced study designs are needed to support epidemiological research that was more appropriate when the ways of consuming nicotine were limited and methods to assess causality in less than decades were unavailable. Given their different perspectives and scientific capabilities, progress in THR requires deeper and transparent engagement between industry scientists and those in academia that rigorously applies conflicts of interest norms.

A Florida House subcommittee has approved a bipartisan proposal to waive the $75 state fee for military veterans applying for medical marijuana cards. The aim is to ease financial and procedural barriers for veterans, especially those with chronic pain or PTSD. While veterans must still meet medical qualifications and pay for doctor certification, the proposal removes the state fee and extends certification renewals from one to two years. Supporters see it as a way to reduce burdens on those who have served.